Company Overview and News

3
The State Of REITs: October 2018 Edition

2018-10-09 seekingalpha
The REIT sector saw its 6-month winning streak of positive total returns snapped with a dismal September.
MPW GOV RMR GOVNI NASDAQILPT CTT ILPT RYN SIR SAFE CMCT STAG

 
SAFE / Safety, Income & Growth Inc. null

2018-10-04 sec.gov
Via Electronic Submission on Edgar October 4, 2018 Divisi
SAFE

 
SAFE / Safety, Income & Growth Inc. / FMR LLC / Fidelity - null (Passive Investment)

2018-09-10 sec.gov
SCHEDULE 13G Amendment No. 2 SAFETY INCOME & GROWTH INC COMMON STOCK Cusip #78649D104 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #78649D104 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 0 Item 6: 0 Item 7: 583,756 Item 8: 0 Item 9: 583,756 Item 11: 3.202% Item 12: HC Cusip #78649D104 Item 1: Reporting Person - Abigail P.
SAFE

 
SAFE / Safety, Income & Growth Inc. / FMR LLC / Fidelity - null (Passive Investment)

2018-09-10 sec.gov
SCHEDULE 13G Amendment No. 2 SAFETY INCOME & GROWTH INC COMMON STOCK Cusip #78649D104 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #78649D104 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 0 Item 6: 0 Item 7: 583,756 Item 8: 0 Item 9: 583,756 Item 11: 3.202% Item 12: HC Cusip #78649D104 Item 1: Reporting Person - Abigail P.
SAFE

 
SAFE / Safety, Income & Growth Inc. null (Quarterly Report)

2018-08-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 <
SAFE

 
Safety Income & Growth, Inc (SAFE) CEO Jay Sugarman on Q2 2018 Results - Earnings Call Transcript

2018-07-29 seekingalpha
Safety Income & Growth, Inc (NYSE:SAFE) Q2 2018 Results Conference Call July 26, 2018 10:00 AM ET
SAFE

 
iStar, Inc. - A Sharpened Focus Should Finally Unlock Large Embedded Value

2018-07-06 seekingalpha
Company is implementing a strategic and accelerated transition of converting non-income producing legacy assets with large embedded profits back into their core businesses.
HHC STAR SAFE NYTAB

 
Can China Withstand A Trade War?

2018-07-04 seekingalpha
Trade tensions are escalating between the US and China, and Trump argues that the US can't lose.
SAFE MS

2
Moving Average Crossover Alert: Safety, Income & Growth (SAFE)

2018-06-13 zacks
Safety, Income & Growth Inc. (SAFE - Free Report) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for SAFE broke out above the 200 Day Simple Moving Average, suggesting a short-term bullish trend.
SAFE

2
SAFE / Safety, Income & Growth Inc. null (Quarterly Report)

2018-05-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SAFE

12
The State Of REITs: May 2018 Edition

2018-05-11 seekingalpha - 1
The REIT rally that began in March grew stronger in April as REITs again outperformed the broader market.
UBA GEO WHLRW WHLR WHIR QCP RVEN WHLRD UBP SAFE WHLRP

2
Safety Income & Growth's (SAFE) CEO Jay Sugarman on Q1 2018 Results - Earnings Call Transcript

2018-04-29 seekingalpha
Safety Income & Growth, Inc. (NYSE:SAFE) Q1 2018 Earnings Conference Call April 26, 2018 10:00 AM ET
SAFE ONXC

2
SAFE / Safety, Income & Growth Inc. null (Annual Report)

2018-04-02 sec.gov
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934
SAFE

2
SAFE / Safety, Income & Growth Inc. 424B3 (Prospectus)

2018-03-12 sec.gov
Table of Contents PROSPECTUS SUPPLEMENT NO. 1
SAFE

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to SAFE / Safety, Income & Growth Inc. on message board site Silicon Investor.

XXII Changing the worlds Cigarette market to a safer place!! XXII Changing the worlds Cigarette market to a safer place!! XXII Changing the worlds Cigarette market to a safer place!! Help Donald Trump create an America Both SAFE and GREAT! Help Donald Trump create an America Both SAFE and GREAT! Help Donald Trump create an America Both SAFE and GREAT!
Linn Energy - A Stock Offering Safe Dividends AND Speculativ Linn Energy - A Stock Offering Safe Dividends AND Speculativ Linn Energy - A Stock Offering Safe Dividends AND Speculativ Safenet - The Name In VPN Security (SFNT) Safenet - The Name In VPN Security (SFNT) Safenet - The Name In VPN Security (SFNT)
Nuvilex inc (former EFSF eFoodSafety.com Nuvilex inc (former EFSF eFoodSafety.com Nuvilex inc (former EFSF eFoodSafety.com ESFS - Eco-Safe Systems USA, Inc. ESFS - Eco-Safe Systems USA, Inc. ESFS - Eco-Safe Systems USA, Inc.
GeckoSystems, Mobile Robot Solutions for Safety , Security a GeckoSystems, Mobile Robot Solutions for Safety , Security a GeckoSystems, Mobile Robot Solutions for Safety , Security a OncoSec Medical (ONCS) Presents Preliminary Safety Data for OncoSec Medical (ONCS) Presents Preliminary Safety Data for OncoSec Medical (ONCS) Presents Preliminary Safety Data for
CEPHALON LTD u0026 THEIR UNSAFE ZACIN CREAM CEPHALON LTD u0026 THEIR UNSAFE ZACIN CREAM CEPHALON LTD u0026 THEIR UNSAFE ZACIN CREAM E-FoodSafety (EFSF) E-FoodSafety (EFSF) E-FoodSafety (EFSF)
CUSIP: 78649D104